430 Results (Page 1 of 18)
UAE Markets Research Reports
UAE In Vitro Fertilisation (IVF) Service Market Analysis
This report presents a strategic analysis of the UAE In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UAE In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy and expert insights.
UAE Healthcare Reimbursement Market Analysis
This report presents a strategic analysis of the UAE Healthcare Reimbursement Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UAE Healthcare Reimbursement Market, offering unmatched value, accuracy and expert insights.
UAE Healthcare Diagnostics Market Analysis
This report presents a strategic analysis of the UAE Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UAE Healthcare Diagnostics Market, offering unmatched value, accuracy and expert insights.
UAE Physiotherapy Market Analysis
The UAE physiotherapy market size was valued at $266 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.85% from 2022 to 2030 and will reach $452 Mn in 2030. UAE physiotherapy market is expected to grow due to an increase in the number of people suffering from chronic conditions such as obesity and diabetes. The market is segmented by Product Type, Application Type, and End User. The major layers in the UAE physiotherapy market Medstar Medical Equipment, Gulf Medical Equipment, Euro Med, Mediplus and others.
UAE Home Healthcare Market Analysis
The UAE home healthcare market was valued at $1.83 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.93% from 2022 to 2030 and will reach $3.59 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, many insurances now include home healthcare. The market is segmented by equipment outlook and by services. Some key players in this market are Omega Home Health Care, Ishraq home healthcare, bayti Home Healthcare, Manzil, Mediclinic, NMC Health, and Alleanza.
UAE Antibacterial (Antibiotics) Drugs Market Analysis
UAE Antibacterial (Antibiotics) Drugs Market is at around $0.25 Bn in 2023 and is projected to reach $0.3 Bn in 2030, exhibiting a CAGR of 5.2% during the forecast period. The market is being driven by the increasing prevalence of infectious diseases, government healthcare initiatives, and growing population and urbanization. The market is dominated by key players like Julphar Gulf Pharmaceutical Industries, Tabuk Pharmaceuticals, Pfizer, AstraZeneca plc, GlaxoSmithKline (GSK), Johnson & Johnson Inc. (J&J), Merck & Co., Sanofi, Novartis, and F. Hoffmann-La Roche Ltd.
UAE Pain Management Devices Market Analysis
This report presents a strategic analysis of the UAE Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the UAE Pain Management Devices Market, offering unmatched value, accuracy and expert insights.
UAE Cholesterol Therapeutics Market Analysis
The UAE Cholesterol Therapeutics Market is anticipated to experience a growth from $122 Mn in 2022 to $161 Mn by 2030, with a CAGR of 3.6% during the forecast period of 2022-2030. The key factors propelling the market growth in the UAE include the rising prevalence of dyslipidemia due to factors like urbanization, western dietary patterns, and obesity, increased awareness about the health risks associated with high cholesterol, and significant government investments and initiatives aimed at improving healthcare facilities. The UAE Cholesterol Therapeutics Market encompasses various players across different segments, Amgen, Pfizer, Merck, AstraZeneca, Johnson & Johnson, Julphar, Cadila, Sinopharm, Sanofi, AbbVie, etc., among various others.
UAE Healthcare Insurance Market Analysis
The UAE healthcare insurance market is projected to grow from $10.131 Bn in 2022 to $19.6 Bn by 2030, registering a CAGR of 8.6% during the forecast period of 2022-2030. The main factors driving the growth would be the increasing population, rising healthcare costs, technological advancements and government support. The market is segmented by the component, provider, coverage, health insurance plans and end-user. Some of the major players include Dubai Islamic Insurance & Reinsurance, MetLife, Abu Dhabi National Insurance, Orient Health, Adamjee, Oman Insurance Company, Ras Al Khaimah National Insurance, Daman, Emirates Insurance and AXA Gulf.
UAE Dental Care Market Analysis
The UAE dental care market size is at around $179 Mn in 2022 and is projected to reach $318 Mn in 2030, exhibiting a CAGR of 7.4% during the forecast period from 2022 to 2030. The market is growing as the new medical tourism destination for dental care services and is dominated by players like American Dental Clinic, Dr. Sulaiman Al Habib Medical Group, Aster DM Healthcare, and Medcare Hospitals & Medical Centers.
UAE Retail Pharmacy Market Analysis
The UAE Retail Pharmacy Market is projected to grow from $5.193 Bn in 2022 to $9.541 Bn by 2030, registering a CAGR of 7.9% during the forecast period of 2022-2030. The market is expected to continue growing at a steady pace in the coming years, with an increasing number of retail pharmacy chains and independent pharmacies opening in the country. Lloyds Pharmacy is a leading retail pharmacy chain in the UAE, with over 70 branches across the country.
UAE Blockchain Technology in Healthcare Market Analysis
This report presents a strategic analysis of the UAE Blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the UAE Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy, and expert insights.
UAE Alzheimer’s Therapeutics Market Analysis
UAE alzheimer’s therapeutics market valued at $24 Mn in 2022, projected to reach $52 Mn by 2030 with a 10.1% CAGR. As the population ages, the prevalence of Alzheimer's disease rises, driving demand for Alzheimer's treatment drugs, one of the major factors driving the market's growth. Leading pharmaceutical companies that are currently working in the market are Pfizer, Eisai, Janssen, Biogen, Roche, Novartis, Lundbeck, Otsuka Pharmaceutical, Teva Pharmaceutical and Sun Pharmaceutical.
UAE Infectious Disease Drugs Market Analysis
UAE Infectious Disease Drugs Market valued at $0.59 Bn in 2023, projected to reach $0.85 Bn by 2030 with a 5.27% CAGR. The market is being driven by the prevalence of infectious diseases, government initiatives, and rising healthcare expenditure. The market is dominated by key players like Hikma Pharmaceuticals, Julphar Gulf Pharmaceutical Industries, Neopharma, AbbVie Inc., Gilead Sciences, GlaxoSmithKline plc, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, and Janssen Pharmaceuticals.
UAE Atopic Dermatitis Therapeutics Market Analysis
The UAE Atopic Dermatitis Therapeutics Market was valued at US $62 Mn in 2022, and is predicted to grow at (CAGR) of 9.8% from 2023 to 2030, to US $130 Mn by 2030. The key drivers of this industry include the upward trend in prevalence of Atopic Dermatitis (AD), supportive government policies, and shifting treatment preferences. The industry is primarily dominated by players such as Sanofi, AbbVie, Pfizer, Bayer, GlaxoSmithKline, and Merck, among others.
UAE Atherosclerosis Therapeutics Market Analysis
UAE Atherosclerosis Therapeutics Market was valued at $14 Mn in 2022 and is estimated to reach $24 Mn in 2030, exhibiting a CAGR of 6.7% during the forecast period. The market for atherosclerosis therapeutics is expected to grow as a result of the growing incidence of cardiovascular diseases, which are being exacerbated by sedentary lifestyles, poor eating habits, and an aging population worldwide. The leading pharmaceutical companies presently operating in the market are Pfizer, Novartis, AstraZeneca, Sanofi, Bayer, Abbott, Johnson & Johnson, Teva Pharmaceutical, Roche and Merck & Co.
UAE Asthma and COPD Therapeutics Market Analysis
The UAE Asthma and COPD Therapeutics Market was valued at US $167 Mn in 2022, and is predicted to grow at (CAGR) of 6.20% from 2023 to 2030, to US $270 Mn by 2030. The key drivers of this industry include the rising prevalence of COPD and asthma, supportive government initiatives, unmet demand, and others. The industry is primarily dominated by players such as, GlaxoSmithKline, Teva, Merck Novartis, AstraZeneca, Pfizer, and Boehringer Ingelheim, among others.
UAE HIV Drugs Market Analysis
UAE HIV Drugs Market is at around $0.16 Bn in 2023 and is projected to reach $0.22 Bn in 2030, exhibiting a CAGR of 4.6% during the forecast period. Factors including improvements in drug development, rising healthcare costs, and migration and tourism are driving the market. The market is dominated by key players like Julphar, Neopharma, Gilead Sciences, ViiV Healthcare, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Merck & Co., Bristol-Myers Squibb, AbbVie Inc., and F. Hoffman-La Roche Ltd.
UAE Antifungal Drugs Market Analysis
UAE Antifungal Drugs Market is at around $0.07 Bn in 2023 and is projected to reach $0.1 Bn in 2030, exhibiting a CAGR of 4.8% during the forecast period. The market is expanding due to factors such as the prevalence of fungal infections, improvements in healthcare infrastructure, and technological advancements in drug development. The market is dominated by key players like Neopharma, Abbott Laboratories, Merck & Co., Inc., Astellas Pharma Inc., Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
UAE Alopecia Drugs (Hair Loss) Market Analysis
UAE alopecia drugs (hair loss) market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of alopecia, rising awareness and consciousness among individuals about their appearance, and the development of advanced treatment technologies. Johnson & Johnson, Merck & Co., GlaxoSmithKline plc, Cipla Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Histogen Inc., Aclaris Therapeutics, and Concert Pharmaceuticals are the key players in this market.
UAE Aminoglycosides Market Analysis
UAE Aminoglycosides Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The Aminoglycosides market is a segment of the pharmaceutical industry that focuses on the production and sale of aminoglycoside antibiotics. Key factors driving the market include the increasing prevalence of bacterial infections, especially drug-resistant strains, which require potent antibiotics like aminoglycosides. The growing geriatric population and the rise in chronic diseases also contribute to the demand for aminoglycosides. The market analysis also considers restraints such as the potential side effects and toxicity associated with aminoglycoside use. These antibiotics can cause serious adverse effects, including kidney damage and hearing loss, which limit their long-term use. Furthermore, the emergence of alternative antibiotics and the growing concern over antibiotic resistance pose challenges to the market growth. Some of the prominent global players in the Aminoglycosides market include Pfizer Inc., Merck & Co., Inc., Novartis AG, Bristol Myers Squibb Company, Eli Lilly and Company, Abbott Laboratories, Johnson & Johnson, Aurobindo Pharma Ltd., Teva Pharmaceutical Industries Ltd., and Mylan N.V.
UAE Anti-Aging Drugs Market Analysis
UAE Anti-Aging Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The Anti-Aging Drugs market is driven by the increasing aging population, advancements in medical research, growing consumer awareness and beauty standards, and the emphasis on preventive healthcare, prompting individuals to seek effective solutions for maintaining a youthful appearance and improving overall well-being. However, the Anti-Aging Drugs market also faces certain restraints. These include stringent regulatory requirements, potential safety concerns, and ethical considerations associated with the use of anti-aging drugs. Additionally, the high cost of some anti-aging drugs may limit their accessibility to a wider population. The Anti-Aging Drugs market is highly competitive, with several key players contributing to its growth and development. Companies such as Allergan, Galderma, Merz Pharma, and Johnson & Johnson are renowned for their expertise in developing and manufacturing anti-aging drugs and treatments.
UAE Anti-Venom Market Analysis
UAE Anti-Venom Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Purified antibodies are used to prevent snake venom from attaching to tissues and causing severe allergic reactions, blood clotting, muscular injury, or nervous system difficulties. The anti-venom market is being driven by the rising global incidence of snakebites, which is fueling demand for effective snakebite treatment options such as anti-venom products. Anti-venom awareness and education efforts have been critical in emphasising the necessity of anti-venom in snakebite management. Manufacturing and delivery techniques advancements have enhanced the safety, efficacy, and accessibility of anti-venom medications. However, market obstacles include restricted access in rural places, high manufacturing costs, a lack of specificity and efficacy in particular formulations, and safety concerns about potential adverse responses and difficulties during therapy.Some global players in the anti-venom market include CSL Limited, BTG plc, Merck & Co., Inc., Pfizer Inc., Sanofi Pasteur SA, Haffkine Bio-Pharmaceutical Corporation Ltd., Rare Disease Therapeutics, Inc., Instituto Bioclon, S.A. de C.V., and Bharat Serums and Vaccines Limited.
UAE Anticoagulants Market Analysis
UAE Anticoagulants Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Anticoagulants, commonly known as blood thinners, reduce the risk of blood clots and related consequences by suppressing the clotting mechanisms in the blood. Increased cardiovascular illnesses, an ageing population, greater awareness, technical improvements, advantageous reimbursement policies, and an increase in surgical operations are driving the anticoagulants market. However, there are hazards of bleeding, regulatory requirements, and generic alternatives. The presence of many prominent companies who play a crucial part in developing the industry characterises the global anticoagulants market. Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company, Limited, Sanofi S.A., Novartis AG, Merck & Co., Inc., and Portola Pharmaceuticals, Inc. are among the prominent participants.
UAE Antiepileptics Drugs Market Analysis
UAE Antiepileptics Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Epilepsy is a chronic neurological disorder characterized by recurrent seizures. The market for antiepileptic drugs is driven by the growing prevalence of epilepsy worldwide and the continuous need for effective and well-tolerated medications. Continuous advances in drug research and development help to bring new and improved antiepileptic treatments to market. These developments result in the creation of pharmaceuticals with improved efficacy, safety profiles, and fewer side effects, which drives market expansion. Some prominent players in the market include UCB Pharma, GlaxoSmithKline plc, Pfizer Inc., Novartis AG, Johnson & Johnson, Sanofi S.A., Eisai Co., Ltd., Sunovion Pharmaceuticals Inc., Cephalon, Inc., and Teva Pharmaceutical Industries Ltd.